CARMELA LUZI: Open Payments
NPI 1538540257 · NEWTOWN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,001 in 109 payments from 16 companies in 2025. Trend: 2023 $2,980 · 2024 $3,279 · 2025 $2,001
Food & beverage: $2,001
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $345 |
| ABBVIE INC. | 23 | $320 |
| UCB, Inc. | 13 | $240 |
| Novartis Pharmaceuticals Corporation | 8 | $205 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $200 |
| Galderma Laboratories, L.P. | 6 | $119 |
| LEO Pharma Inc. | 6 | $118 |
| Lilly USA, LLC | 5 | $114 |
| Organon LLC | 7 | $84 |
| GENZYME CORPORATION | 3 | $58 |
Products named: TREMFYA, Bimzelx, SKYRIZI, Winlevi, ADBRY, DUPIXENT, EBGLYSS, NEMLUVIO.
Industry payments across CT — which companies pay providers there.
